The effect of CdSe–ZnS quantum dots on calcium currents and catecholamine secretion in mouse chromaffin cells
Source abstract
Abstract
Semiconductor nanocrystal quantum dots (QDs) possess an enormous potential of applications in nanomedicine, drug delivery and bioimaging which derives from their unique photoemission and photostability characteristics. In spite of this, however, their interactions with biological systems and impact on human health are still largely unknown. Here we used neurosecretory mouse chromaffin cells of the adrenal gland for testing the effects of CdSe-ZnS core-shell quantum dots (5-36 nM) on Ca(2+) channels functionality and Ca(2+)-dependent neurosecretion. Prolonged exposure (24 h) to commonly used concentrations of CdSe-ZnS QDs (≥16 nM) showed that the semiconductor nanocrystal is effectively internalized into the cells without affecting cell integrity (no changes of membrane resistance and cell capacitance). QDs reduced the size of Ca(2+) currents by ∼28% in a voltage-independent manner without affecting channel gating. Correspondingly, depolarization-evoked exocytosis, measured at +10 mV, where Ca(2+) currents are maximal, was reduced by 29%. CdSe-ZnS QDs reduced the size of the readily releasable pool (RRP) of secretory vesicles by 32%, the frequency of release by 33% and the overall quantity of released catecholamines by 61%, as measured by carbon fibers amperometry. In addition, the Ca(2+)-dependence of exocytosis was reduced, whereas the catecholamine content of single granules, as well as the kinetics of release, remained unaltered. These data suggest that exposure to CdSe-ZnS QDs impairs Ca(2+) influx and severely interferes with the functionality of the exocytotic machinery, compromising the overall catecholamine supply from chromaffin cells.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Quantum Dots Synthesis And Properties · Chalcogenide Semiconductor Thin Films · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (65)
Show source-provided references
1. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors10.1289/ehp.8284 ↗
2. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modifications10.1021/nl048715d ↗
3. Mechanism of quantum dot nanoparticle cellular uptake10.1093/toxsci/kfp087 ↗
4. In vitro diagnostic prospects of nanoparticles10.1016/j.cca.2009.01.016 ↗
5. Application of quantum dots-based biotechnology in cancer diagnosis: current status and future perspectives
6. In vivo imaging of quantum dots encapsulated in phospholipid micelles10.1126/science.1077194 ↗
7. Tracking bio-molecules in live cells using quantum dots10.1002/jbio.200810029 ↗
8. Simultaneous multicolor imaging of five different lymphatic basins using quantum dots10.1021/nl0707003 ↗
9. The dynamic control of kiss-and-run and vesicular reuse probed with single nanoparticles10.1126/science.1167373 ↗
10. Movements of individual BK Ca channels in live cell membrane monitored by site-specific labeling using quantum dots10.1016/j.bpj.2010.08.049 ↗
11. Quantum dot induced epigenetic and genotoxic changes in human breast cancer cells10.1007/s00109-007-0274-2 ↗
12. Nanoparticles for biomedical imaging: fundamentals of clinical translation10.2310/7290.2010.00031 ↗
13. State of academic knowledge on toxicity and biological fate of quantum dots10.1093/toxsci/kfp188 ↗
14. Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots10.1016/j.taap.2009.04.010 ↗
15. In vitro cytotoxicity evaluation of biomedical nanoparticles and their extracts10.1002/jbm.a.32533 ↗
16. Quantum dots as cellular probes10.1146/annurev.bioeng.7.060804.100432 ↗
17. Effect of ligand density on the spectral, physical, and biological characteristics of CdSe/ZnS quantum dots10.1021/bc700404v ↗
18. Quantum dots for live cells, in vivo imaging, and diagnostics10.1126/science.1104274 ↗
19. The internalized CdSe/ZnS quantum dots impair the chondrogenesis of bone marrow mesenchymal stem cells10.1002/jbm.b.30517 ↗
20. Studies of intracorneal distribution and cytotoxicity of quantum dots: risk assessment of eye exposure10.1021/tx100376n ↗
21. An investigation into the potential for different surface-coated quantum dots to cause oxidative stress and affect macrophage cell signaling in vitro10.3109/17435390903276925 ↗
22. Mechanisms of unmodified CdSe quantum dot-induced elevation of cytoplasmic calcium levels in primary cultures of rat hippocampal neurons10.1016/j.biomaterials.2008.08.001 ↗
23. Unmodified CdSe quantum dots induce elevation of cytoplasmic calcium levels and impairment of functional properties of sodium channels in rat primary cultured hippocampal neurons10.1289/ehp.11225 ↗
24. Peptide-conjugated quantum dots activate neuronal receptors and initiate downstream signaling of neurite growth10.1021/nl047977c ↗
25. The effect of quantum dots on synaptic transmission and plasticity in the hippocampal dentate gyrus area of anesthetized rats10.1016/j.biomaterials.2009.06.012 ↗
26. PDE type-4 inhibition increases L-type Ca2+ currents, action potential firing, and quantal size of exocytosis in mouse chromaffin cells10.1007/s00424-008-0584-4 ↗
27. Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules10.1016/S0896-6273(00)80147-6 ↗
28. Chronic hypoxia up-regulates alpha1H T-type channels and low-threshold catecholamine secretion in rat chromaffin cells10.1113/jphysiol.2007.132274 ↗
29. The impact of CdSe/ZnS quantum dots in cells of Medicago sativa in suspension culture
30. Biocompatibility of trypan blue with human corneal cells10.1001/archopht.122.5.736 ↗
31. Synthesis, physicochemical characterization, and biological activities of new carnosine derivatives stable in human serum as potential neuroprotective agents10.1021/jm101394n ↗
32. Clathrin-mediated endocytosis of quantum dot peptide conjugates in living cells10.1021/nn900663r ↗
33. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes10.1021/nl070363y ↗
34. Endo- and exocytosis of zwitterionic quantum dot nanoparticles by live Hela cells10.1021/nn101277w ↗
35. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction10.1038/nbt929 ↗
36. Fate of micelles and quantum dots in cells10.1016/j.ejpb.2006.08.011 ↗
37. Dynamics and mechanisms of quantum dot nanoparticle cellular uptake
38. Cytotoxicity of metal and semiconductor nanoparticles indicated by cellular micromotility10.1021/nn800721j ↗
39. Induction of autophagy in porcine kidney cells by quantum dots: a common cellular response to nanomaterials?10.1093/toxsci/kfn137 ↗
40. Cytotoxicity of nanoparticles10.1002/smll.200700595 ↗
41. Long -term exposure of CdTe quantum dots on PC12 cellular activity and the determination of optimum non-toxic concentrations for biological use
42. Experimental approach for an in vitro toxicity assay with non-aggregated quantum dots10.1016/j.tiv.2009.05.007 ↗
43. Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells10.1523/JNEUROSCI.4961-09.2010 ↗
44. Distinct potentiation of L-type currents and secretion by cAMP in rat chromaffin cells10.1016/S0006-3495(03)74567-6 ↗
45. Localized secretion of ATP and opioids revealed through single Ca2+ channel modulation in bovine chromaffin cells10.1016/S0896-6273(00)80505-X ↗
46. Are Cav1.3 pacemaker channels in chromaffin cells? Possible bias from resting cell conditions and DHP blocker usage10.4161/chan.5.3.15271 ↗
47. Mouse chromaffin cells have two populations of dense core vesicles10.1152/jn.00316.2005 ↗
48. Calcium signaling and exocytosis in adrenal chromaffin cells10.1152/physrev.00039.2005 ↗
49. Cav1.3 and BK channels for timing and regulating cell firing10.1007/s12035-010-8151-3 ↗
50. Calcium channel block by cadmium in chicken sensory neurons10.1073/pnas.86.5.1736 ↗
51. Altered excitability of cultured chromaffin cells following exposure to multi-walled carbon nanotubes
52. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles10.1021/nl047996m ↗
53. Probing the cytotoxicity of semiconductor quantum dots10.1021/nl0347334 ↗
54. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death10.1016/j.chembiol.2005.09.008 ↗
55. CdSe quantum dots induce apoptosis in human neuroblastoma cells via mitochondrial-dependent pathways and inhibition of survival signals10.1016/j.toxlet.2006.09.007 ↗
56. Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements10.1021/nl0603350 ↗
57. Time-dependent photoluminescence blue shift of the quantum dots in living cells: effect of oxidation by singlet oxygen10.1021/ja061225y ↗
58. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes10.1038/sj.jid.5700508 ↗
59. The biocompatibility of amino functionalized CdSe/ZnS quantum-dot-doped SiO2 nanoparticles with primary neural cells and their gene carrying performance10.1016/j.biomaterials.2010.04.063 ↗
60. Nanoparticle effects on rat alveolar epithelial cell monolayer barrier properties10.1016/j.tiv.2007.04.003 ↗
61. Advanced optical imaging reveals the dependence of particle geometry on interactions between CdSe quantum dots and immune cells10.1002/smll.201001619 ↗
62. Delivering quantum dot-peptide bioconjugates to the cellular cytosol: escaping from the endolysosomal system10.1039/c0ib00002g ↗
63. Cadmium is more toxic to LLC-PK1 cells than to MDCK cells acting on the cadherin-catenin complex10.1152/ajprenal.1998.275.1.F143 ↗
64. Pathways that control cortical F-actin dynamics during secretion10.1023/A:1021627800918 ↗
65. Increased secretory capacity of mouse adrenal chromaffin cells by chronic intermittent hypoxia: involvement of protein kinase10.1113/jphysiol.2007.140624 ↗